^
    BIOMARKER:

    HER-2 positive

    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
    Contact us to learn more about our Premium Content:
    News alerts, weekly reports and conference planners
    Entrez ID:
    2064
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    HER-2 positive
    Colorectal Cancer
    trastuzumab + tucatinib
    Sensitive
    :
    B
    Seagen Press Release - 1 week - (New B)
    HER-2 positive
    HER2 Positive Breast Cancer
    MAM-06.301
    Sensitive
    :
    D
    Cancer Cell Int - 1 week - (New D)
    HER-2 positive
    HER2 Positive Breast Cancer
    trastuzumab + pyrotinib
    Sensitive
    :
    B
    ESMO 2022 - 3 weeks - (New B)
    HER-2 positive
    Gastric Cancer
    KN046 + KN026
    Sensitive
    :
    C3
    ESMO 2022 - 3 weeks - (New C3)
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    KN046 + KN026
    Sensitive
    :
    C3
    ESMO 2022 - 3 weeks - (New C3)
    HER-2 positive
    HER2 Positive Breast Cancer
    trastuzumab + tucatinib
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    trastuzumab + pertuzumab
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    margetuximab
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    fam-trastuzumab deruxtecan-nxki
    Sensitive
    :
    A1
    HER-2 positive
    Gastric Cancer
    fam-trastuzumab deruxtecan-nxki
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    fam-trastuzumab deruxtecan-nxki
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    ado-trastuzumab emtansine
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    trastuzumab
    Sensitive
    :
    A1
    HER-2 positive
    Gastric Cancer
    pembrolizumab + trastuzumab
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    pertuzumab / trastuzumab / hyaluronidase-zzxf
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab-qyyp
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab-dttb
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab-dkst
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab-anns
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    trastuzumab-pkrb
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    neratinib
    Sensitive
    :
    A1
    HER-2 positive
    Salivary Gland Cancer
    trastuzumab
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    Zercepac (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 positive
    HER2 Positive Breast Cancer
    Zercepac (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 positive
    Gastric Cancer
    Zercepac (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 positive
    Gastroesophageal Junction Adenocarcinoma
    pembrolizumab + trastuzumab
    Sensitive
    :
    A1
    HER-2 positive
    Colorectal Cancer
    trastuzumab + pertuzumab
    Sensitive
    :
    A1
    HER-2 positive
    Gastric Cancer
    trastuzumab
    Sensitive
    :
    A2
    HER-2 positive
    HER2 Positive Breast Cancer
    THP
    Sensitive
    :
    A2
    HER-2 positive
    HER2 Positive Breast Cancer
    TCHP
    Sensitive
    :
    A2
    HER-2 positive
    HER2 Positive Breast Cancer
    trastuzumab + abemaciclib
    Sensitive
    :
    A2
    HER-2 positive
    HER2 Positive Breast Cancer
    TCH
    Sensitive
    :
    A2
    HER-2 positive
    HER2 Positive Breast Cancer
    trastuzumab + lapatinib
    Sensitive
    :
    A2
    HER-2 positive
    Gastroesophageal Cancer
    trastuzumab
    Sensitive
    :
    A2
    HER-2 positive
    Esophageal Adenocarcinoma
    trastuzumab
    Sensitive
    :
    A2
    HER-2 positive
    Endometrial Cancer
    trastuzumab
    Sensitive
    :
    A2